A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.
about
Relevance of genetic alterations in squamous and small cell lung cancer.Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer.Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
P2860
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A Phase Ib Open-Label Multicen ...... ed Squamous Cell Lung Cancers.
@en
type
label
A Phase Ib Open-Label Multicen ...... ed Squamous Cell Lung Cancers.
@en
prefLabel
A Phase Ib Open-Label Multicen ...... ed Squamous Cell Lung Cancers.
@en
P2093
P2860
P1476
A Phase Ib Open-Label Multicen ...... ed Squamous Cell Lung Cancers.
@en
P2093
Alastair Mathewson
Claire Rooney
David Ferry
Donal Landers
Elaine Kilgour
Marie Cullberg
Michael F Berger
Neil R Smith
Nigel Brooks
Paul Frewer
P2860
P304
P356
10.1158/1078-0432.CCR-17-0645
P407
P577
2017-06-14T00:00:00Z